Mabwell (Shanghai) Bioscience Co., Ltd.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 688062.SS | 2696.HK | SMZ1.F | 688382.SS | 8SJ.F | 2162.HK | |
|---|---|---|---|---|---|---|
| Market cap | 10.13B | 27.67B | 11.09B | 8.38B | 1.84B | 20.67B |
| P/E (TTM) | — | 28.8 | 31.2 | — | — | 23.8 |
| Forward P/E | -21.6 | 28.2 | — | -43.8 | — | 206.8 |
| Price/book | 14.1 | 5.2 | 2.6 | 6.6 | 2.4 | 4.4 |
| Dividend yield | — | — | 2.90% | — | — | — |
| 1-year change | −51.34% | −19.71% | −23.60% | −48.70% | −37.59% | +8.65% |
| Today | +5.29% | +1.78% | +1.45% | +4.33% | +1.70% | +2.48% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All 688062.SS news ›Mabwell (Shanghai) Bioscience Co., Ltd.: Relative Strength Chart - Stock Shanghai S.E.
Compare Mabwell (Shanghai) Bioscience Co., Ltd. with the company of your choice via a Relative Strength chart. Real-time 688062 price, Shanghai S.E. stock exchange Relative Strength Chart Mabwell (Shanghai) Bioscience Co., Ltd.…
Mabwell Shanghai Bioscience COPD Drug Shows Positive Efficacy
Mabwell Shanghai Bioscience said its novel monoclonal antibody 9MW1911 demonstrated strong efficacy signals in reducing exacerbations in patients with moderate-to-severe chronic obstructive... Mabwell (Shanghai) Bioscience Co., Ltd.…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.